Complete Response of a Patient with Squamous Cell Carcinoma of the Sigmoid Colon: A Case Report
Categoria dell'articolo: Research Article
Pubblicato online: 08 mar 2025
Pagine: 90 - 96
Ricevuto: 28 apr 2024
Accettato: 12 ott 2024
DOI: https://doi.org/10.2478/fco-2023-0043
Parole chiave
© 2024 Yaala Saady Raof Al-Bairmany, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Background
Squamous cell carcinoma of the sigmoid colon is an exceedingly rare and often late-diagnosed form of colon cancer. It presents diagnostic and therapeutic challenges due to its rarity and nonspecific symptoms. This case report aims to enhance understanding and awareness of this uncommon malignancy.
Case Presentation
We present the case of a 59-year-old female with advanced stage squamous cell carcinoma of the sigmoid colon, accompanied by metastases to regional lymph nodes, peritoneum, and omentum. Initial imaging and colonoscopy confirmed the diagnosis, and due to the absence of established treatment guidelines, a unique chemotherapy regimen combining paclitaxel, carboplatin, and bevacizumab was initiated. Remarkably, the patient exhibited a significant improvement in performance status and achieved complete remission following 16 weeks of treatment.
Conclusion
This case highlights the diagnostic challenges and therapeutic complexities associated with squamous cell carcinoma of the sigmoid colon. The exceptional response to tailored chemotherapy underscores the importance of individualized treatment approaches in rare malignancies. Further research and clinical trials are warranted to establish effective therapeutic strategies and improve patient outcomes in similar cases.